Sunshine Biopharma (SBFM) Free Cash Flow (2010 - 2026)
Sunshine Biopharma (SBFM) posted Free Cash Flow of -$2.1 million for Q1 2026, down 28.62% on a QoQ basis from -$1.6 million in Q4 2025, and down 22.01% year-over-year from -$2.7 million in Q1 2025.
Sunshine Biopharma (SBFM) Free Cash Flow (2010 - 2026) Analysis & Trends
Sunshine Biopharma's Free Cash Flow history runs 17 years deep, the most recent figure standing at -$2.1 million for Q1 2026.
- Quarterly Free Cash Flow fell 22.01% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.9 million (up 53.46% YoY) and the FY2025 annual result came in at -$5.5 million, up 61.18% from the prior year.
- Free Cash Flow was -$2.1 million for Q1 2026 at Sunshine Biopharma, down from -$1.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$466923.0 in Q3 2023 and bottomed at -$5.6 million in Q2 2024.
- A 5-year average of -$2.1 million and a median of -$1.9 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow sank 681.96% — and 2025, when it jumped 73.84%.
- Sunshine Biopharma's Free Cash Flow stood at -$2.4 million in 2022, then climbed by 5.46% to -$2.3 million in 2023, then sank by 52.03% to -$3.5 million in 2024, then soared by 53.96% to -$1.6 million in 2025, then fell by 28.62% to -$2.1 million in 2026.
- Business Quant data shows SBFM's Free Cash Flow at -$2.1 million in Q1 2026, -$1.6 million in Q4 2025, and -$735840.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 363.70 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | -2.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.08 Mn |
| Mar 31, 2026 | -2.08 Mn |
| Dec 31, 2025 | -1.61 Mn |
| Dec 31, 2025 | -1.61 Mn |
| Sep 30, 2025 | -735,840.00 |
| Sep 30, 2025 | -735,840.00 |
| Jun 30, 2025 | -1.45 Mn |
| Jun 30, 2025 | -1.45 Mn |
| Mar 31, 2025 | -1.70 Mn |
| Mar 31, 2025 | -1.70 Mn |
| Dec 31, 2024 | -3.51 Mn |
| Dec 31, 2024 | -3.51 Mn |
| Sep 30, 2024 | -1.87 Mn |
| Sep 30, 2024 | -1.87 Mn |
| Jun 30, 2024 | -5.55 Mn |
| Jun 30, 2024 | -5.55 Mn |
| Mar 31, 2024 | -3.25 Mn |
| Mar 31, 2024 | -3.25 Mn |
| Dec 31, 2023 | -2.31 Mn |
| Dec 31, 2023 | -2.31 Mn |